Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1462 participants.
Also called NCT03067441
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,462 participants
- Sponsor
- Registry
-
NCT03067441 -
2016-004115-12
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03067441. Allocation not applicable; no masking; primary purpose treatment. Start 2017-02-03 (actual); primary completion 2019-11-05 (actual). Results posted on 2020-12-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
- Condition
- Hypercholesterolemia
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- bempedoic acid
- Lead sponsor
- Esperion Therapeutics, Inc.
Record details
- Record id
cardio:ct-nct03067441- Content hash
93f775726760a4d2e71bbae70a1ab83e2547d4d6f64927c97da1ffccebea8b2b